Targeting MET in EGFR-Mutated NSCLC.

Saved in:
Bibliographic Details
Title: Targeting MET in EGFR-Mutated NSCLC.
Authors: Saw SPL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore. Electronic address: stephanie.saw.p.l@singhealth.com.sg., Li MSC; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China., Park S; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Hatano H; Department of Respiratory Medicine, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan., Uehara Y; Department of Experimental Therapeutics/Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Menis J; Department of Medical Oncology, University Hospital of Verona, Verona, Italy., Brandão M; Thoracic Oncology Functional Unit, Department of Medical Oncology, Institut Jules Bordet- Hôpital Universitaire de Bruxelles (H.U.B.), Université Libre de Bruxelles (ULB), Brussels, Belgium., Hendriks LEL; Department of Pulmonary Diseases - GROW Research Institute for Oncology and Reproduction, Maastricht UMC+, Maastricht, The Netherlands., Remon J; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Apr 02, pp. 103711. Date of Electronic Publication: 2026 Apr 02.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1016/j.jtho.2026.103711